BNOX

Companies
NASDAQ
Bionomics Limited
Health Care
Price Chart
Overview

About BNOX

Bionomics Ltd is a global, clinical-stage biopharmaceutical company. It is primarily engaged in the development of therapeutics for diseases of the central nervous system and cancer. The company's reportable segment is the Drug Discovery and Development segment which is engaged in the discovery, development, and commercialization of compounds to match a target product profile. The company generates all of its revenues from Australia.

Market Cap
$7.6M
Volume
2.2M
Avg. Volume
5.4M
P/E Ratio
-0.13607527
Dividend Yield
0.00%
Employees
20.0

Company Information

Exchange
NASDAQ
Sector
Health Care
Industry
Biotechnology
Risk & Correlation Analysis
Market Correlation
0.29
Low Correlation
Volatility
High (1.00)
Relative to market
Portfolio Impact
Forecasts & Predictions

Premium Forecasts

Get AI-powered price predictions, technical analysis, and market forecasts for BNOX.

1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential

Technical Analysis

Based on technical indicators and chart patterns, BNOX shows...

AI Sentiment Analysis

Market sentiment analysis indicates...

Key Statistics
Market Cap$7.6M
Volume2.2M
P/E Ratio-0.14
Dividend Yield0.00%
Related Securities

PortfolioPilot Analysis

Get AI-powered insights on how BNOX fits into your investment strategy and portfolio diversification.

Pricing info last updated June 17, 2025 (after market close)Other info last updated April 2, 2025